Goldman Sachs
BIOA

Goldman Sachs’s BioAmber Inc. BIOA Stock Holding History

Goldman Sachs’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,975
Closed -$47K – 7242
2016
Q3 		$47K Buy
10,975
+189
+2% +$698 ﹤0.01% 6498
2016
Q2 		$32K Sell
10,786
-193
-2% -$704 ﹤0.01% 6577
2016
Q1 		$46K Buy
+10,979
New +$46.1K ﹤0.01% 6471
2015
Q4 		– Sell
-11,969
Closed -$64K – 7520
2015
Q3 		$64K Sell
11,969
-2,218
-16% -$14.6K ﹤0.01% 6691
2015
Q2 		$122K Buy
14,187
+2,370
+20% +$21.7K ﹤0.01% 6512
2015
Q1 		$103K Sell
11,817
-2,731
-19% -$24K ﹤0.01% 6412
2014
Q4 		$122K Sell
14,548
-6,359
-30% -$57.9K ﹤0.01% 6488
2014
Q3 		$209K Sell
20,907
-11,026
-35% -$129K ﹤0.01% 6129
2014
Q2 		$318K Buy
31,933
+14,500
+83% +$150K ﹤0.01% 5764
2014
Q1 		$199K Buy
17,433
+1,600
+10% +$19K ﹤0.01% 6089
2013
Q4 		$118K Sell
15,833
-667
-4% -$4.57K ﹤0.01% 6214
2013
Q3 		$81K Sell
16,500
-6,700
-29% -$38.1K ﹤0.01% 6214
2013
Q2 		$158K Buy
+23,200
New +$172K ﹤0.01% 5709

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs's BIOA Position: Q4 2016 in Review

Goldman Sachs sold out of BioAmber Inc. (BIOA) in Q4 2016, closing a stake of 10,975 shares — an estimated $47K sold.

Goldman Sachs first reported a position in BIOA in Q2 2013 and held it in 13 quarters. The position peaked at $318K in Q2 2014. 32 funds tracked by Wall St. Rank hold BIOA as of Q4 2016.

  • Goldman Sachs reported no remaining BioAmber Inc. position as of Q4 2016 after selling out during the quarter.
  • Goldman Sachs sold 10,975 BioAmber Inc. shares in Q4 2016, an estimated $47K.
  • Goldman Sachs first reported a position in BioAmber Inc. in Q2 2013 and held it in 13 quarters.
  • Goldman Sachs's BioAmber Inc. position peaked at $318K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2016.

Based on Goldman Sachs's 13F filing for Q4 2016, filed 14 Feb 2017.